Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1468-3083.2009.03455.xDOI Listing

Publication Analysis

Top Keywords

angiokeratoma regression
4
regression fabry
4
fabry disease
4
disease treatment
4
treatment agalsidase-beta
4
agalsidase-beta clinical
4
clinical effectiveness
4
effectiveness marker?
4
angiokeratoma
1
fabry
1

Similar Publications

Angiokeratomas are the cutaneous hallmark of Fabry disease. Although it is well established that enzyme replacement therapy (ERT) prevents or slows the progression of disease on target organs in the majority of patients, the long-term effect of ERT on angiokeratomas remains unknown. We present a patient diagnosed with Fabry disease at age 11, with rapid progression of new angiokeratomas in typical regions before beginning treatment with ERT.

View Article and Find Full Text PDF

Introduction: In advanced Fabry nephropathy stages, enzyme replacement theraphy (ERT) efficacy decreases, due to its impossibility to reverse renal fibrosis. Therefore, the finding of early kidney fibrosis biomarkers in affected patients is of interest. During renal fibrosis miR-21, miR-192 and miR-433 (fibrosis promotors) are activated by transforming growth factor- (TGF-), and miR-29 and miR-200 family (fibrosis supressors) are inhibited by TGF-.

View Article and Find Full Text PDF

A 20-year-old male presented with multiple eruptions on his right leg since birth; these bled and were painful on trivial trauma. Examination revealed dark brown, hyperkeratotic, indurated, verrucous linear plaques with irregular borders. Histopathological evidence of hyperkeratosis, acanthosis, and extensive vascular proliferation in papillary dermis confirmed clinical suspicion of angiokeratoma circumscriptum (AKC).

View Article and Find Full Text PDF

Eccrine angiomatous hamartoma: a retrospective study of 15 cases.

Chang Gung Med J

August 2012

Department of Dermatology, Chang Gung Memorial Hospital at Taipei, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Background: Eccrine angiomatous hamartoma (EAH) comprises a rare nevoid proliferation of normal eccrine glands and small blood vessels and occasionally other elements in the middle and deep dermis with variable clinical manifestations. Case series have rarely been published except for case reports and literature reviews. The aims of this article were to investigate the clinical and pathologic features of patients with EAH in Taiwan and to compare our results with the results of previous studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!